_ Kowa Pharmaceutical Europe Co. Ltd. Innovation through collaboration Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities. Kowa are committed to improving health standards in Europe and globally. FIND OUT MORE Available products Principle investigational drugs Pemafibrate K-877 Ripasudil K-321 Our treatment areas We proudly supply a wide range of products from prescription medicines to retinal cameras and other medical diagnostic products. Lifestyle-related diseases Immunity inflammation Sensory organ diseases Diagnostic devices Kowa is committed to the global healthcare community. ¥422,576m Sales Fiscal year March 31 2020 Kowa Group Consolidated 6,583 Employees March 2020 Kowa Group Consolidated 44 Major subsidiaries Affiliates in Japan, Asia, North America, Latin America, and Europe OUR GLOBAL FAMILY Our history Across our entire group, we have more than 120 years of experience in business and we are proud of our Japanese influence and heritage. Find out more Research & development Tokyo New Drug Research Laboratories and Fuji Laboratory are the core centres for Kowa Company Ltd.’s research and development activities in Japan and globally. In 2009 Kowa and Brigham and Women’s Hospital Harvard University announced the opening of The Center for Interdisciplinary Cardiovascular Sciences (CICS) to promote discovery and advancement in cardiovascular research. View our pipeline Latest news Kowa Company, Ltd. has renewed its corporate website. Take a look at the fresh new website here: https://www.kowa.co.jp/eng Read more By continuing to browse the site, you are agreeing to our use of cookies. Find out more OK Kowa Pharmaceutical Europe Co. Ltd. 105 Wharfedale Road Winnersh Triangle Wokingham Berkshire, RG41 5RB CONTACT US Our products Livazo Avansee Research & development Pipeline Pemafibrate K-877 Ripasudil K-321 Adverse event reporting Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products. REPORT ADVERSE EVENT Copyrights © 2020 Kowa Pharmaceutical Europe Co. Ltd. All rights reserved. Date of preparation: 11 / 2020 UIN: KPE20 00002 Privacy policy Cookie policy Terms of use